Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma
Open Access
- 1 April 2002
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 39 (4) , 260-265
- https://doi.org/10.1136/jmg.39.4.260
Abstract
Background: Papillary thyroid carcinoma (PTC), which may be sporadic (95%) or familial (5%), has a prevalence adjusted for age in the general population of 1:100 000. Somatic rearrangements of the RET proto-oncogene are present in up to 66% of sporadic tumours, while they are rarely found in familial cases. Purpose: In order to determine if some variants of this gene, or a combination of them, might predispose to PTC, we looked for an association of RET haplotype(s) in PTC cases and in controls from four countries matched for sex, age, and population. Methods: Four single nucleotide polymorphisms (SNPs) across the RET coding sequence were typed and haplotype frequencies were estimated. Genotype and haplotype distributions were compared among these cases and controls. Results: Ten haplotypes were observed, the seven most frequent of which have been previously described in sporadic Hirschsprung patients and controls. The single locus analyses suggested association of exon 2 and exon 13 SNPs with sporadic PTC. The haplotype analysis showed over-representation of one haplotype in French and Italian sporadic PTC, whereas a different haplotype was significantly under-represented in French familial PTC. Conclusions: Our data suggest that some variants of RET and some specific haplotypes may act as low penetrance alleles in the predisposition to PTC.Keywords
This publication has 50 references indexed in Scilit:
- Familial thyroid cancerCurrent Opinion in Oncology, 2001
- Genetic Heterogeneity in Familial Nonmedullary Thyroid Carcinoma: Exclusion of Linkage to RET, MNG1, and TCO in 56 FamiliesJournal of Clinical Endocrinology & Metabolism, 1999
- A Novel 9-Base Pair Duplication in RET Exon 8 in Familial Medullary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 1999
- Molecular Analysis of the ret and GDNF Genes in a Family with Multiple Endocrine Neoplasia Type 2A and Hirschsprung DiseaseJournal of Clinical Endocrinology & Metabolism, 1998
- A New Hot Spot for Mutations in the ret Protooncogene Causing Familial Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2AJournal of Clinical Endocrinology & Metabolism, 1998
- A Novel Point Mutation in the Intracellular Domain of the ret Protooncogene in a Family with Medullary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 1997
- Germline Dinucleotide Mutation in Codon 883 of the RETProto-Oncogene in Multiple Endocrine Neoplasia Type 2B Without Codon 918 MutationJournal of Clinical Endocrinology & Metabolism, 1997
- Mutation of RET codon 768 is associated with the FMTC phenotypeClinical Genetics, 1997
- Loss of function effect of RET mutations causing Hirschsprung diseaseNature Genetics, 1995
- RET proto-oncogene mutations in French MEN 2A and FMTC familiesHuman Molecular Genetics, 1994